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Congenital complete heart block (CHB) occurs in approx-
imately 1 in 15,000 live births.1 It may result from an
immune- or non-immune-mediated process, with immune-
mediated cases usually associated with high-titer maternal
anti-Ro antibodies, which cross the placenta and may
result in injury to the fetal cardiac conduction tissues.2
Autoimmune-mediated congenital CHB is associated with
signiﬁcant morbidity and mortality in the perinatal period.2
One study reported a total mortality rate of CHB to be 19%,
of which 27% died in utero and 45% died within the ﬁrst 3
months of life.2 Risk factors for poor fetal outcome include
premature delivery, fetal hydrops, low heart rate, and
ventricular endocardial ﬁbroelastosis.3 CHB is known to
decrease cardiac output in postnatal patients.4 However, the
hemodynamics of the fetal circulation in the setting of CHB
have not been well characterized. Fetal echocardiography
can be used to detect and analyze fetal arrhythmias.
Mechanical assessment by M mode can be used to character-
ize fetal bradycardia including CHB, and pulsed Doppler
is also widely employed to visualize the temporal relation-
ships of the blood ﬂows in the heart and great vessels
that delineate the timing of cardiac electrical events.4
New magnetic resonance imaging (MRI) technology now
provides an additional noninvasive method for measuring
the oxygen saturation (SaO2) and ﬂow in fetal blood
vessels. The feasibility of this MRI technique, which
incorporates a combination of cine phase-contrast MRI
and T2 mapping, has been shown in normal fetal circula-
tion, and in fetuses with congenital heart disease and
intrauterine growth restriction, and we were interested toKEYWORDSMRI; Fetus; Complete heart block; Circulation; Growth restriction
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CHB.5–8Case report
Fetal bradycardia was ﬁrst noted in a 26-year-old mother
with systemic lupus erythematosis during a routine obstetric
anatomy scan at 19 weeks gestation. The pregnancy had
otherwise been uncomplicated, although screening for auto-
antibodies revealed an elevated anti-Ro titer. At the ﬁrst
echocardiogram, the fetus was found to be in second-degree
heart block, with an atrial rate of 149 beats per minute (bpm)
and ventricular rate of 73 bpm without signs of cardiac
dysfunction, endocardial ﬁbroelastosis, or effusions.
The estimated fetal weight was on the 40th percentile.
The mother was started on a course of dexamethasone and
intravenous immunoglobulin. By 20 weeks, the atrioven-
tricular conduction had progressed to CHB (Figure 1)
(Philips iE33; Philips ATL, Bothell, WA) and the fetal heart
rate had dropped to 50 bpm. The patient was started on oral
salbutamol at 34 weeks gestation to maintain fetal heart rates
between 51 and 55 bpm until delivery. At 36 weeks gestation
the fetus was delivered by cesarean section for nonreassuring
biophysical proﬁle, and was born in good condition weigh-
ing 2020 g (below 3rd percentile). The birth weight and
fetal growth curve, produced using ultrasound biometry
(Figure 2), were in keeping with intrauterine growth restric-
tion (IUGR). The heart rate at birth was 50 bpm and a
permanent pacemaker was placed with epicardial ventricular
leads. The infant was discharged from the hospital at
8 days of age with ventricular pacing at 120 bpm, a systolic
blood pressure of 62–78 mm Hg and arterial SaO2 of
96%–98%.Fetal MRI hemodynamic assessment
After obtaining informed consent as part of a hospital ethics
board–approved study, a fetal MRI scan was performed at 35pen access article under the CC BY-NC-ND license
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KEY TEACHING POINTS
 Bradycardia in a complete heart block fetus is
associated with a signiﬁcant reduction in fetal
combined ventricular output, resulting in restricted
fetal growth and elevated oxygen extraction.
 Magnetic resonance imaging (MRI) conﬁrmed the
“brain-sparing physiology” that was indicated by
the Doppler assessment.
 MRI hemodynamic assessment could provide a
useful adjunct to conventional ultrasound
parameters in the monitoring of fetal well-being in
complete heart block.
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Avanto, Erlangen, Germany) according to our previously
published technique.5,6 Three-dimensional volumetry pro-
vided an estimation of fetal weight of 1950 g, which was at
the 2nd percentile for gestational age. The fetal heart rate was
at about 50 bpm at the time of the MRI scan. A reconstruc-
tion technique called metric optimized gating was used for
retrospective cardiac triggering, allowing high-resolution
time-resolved phase-contrast MRI measurements of fetal
blood ﬂow. An example of ﬂow measurement in the fetal
descending aorta (DAo) is shown in Appendix 1 (supple-
mental material available online). The phase-contrast results
were compared with reference ranges (mean  2 standard
deviations).5 The results showed low normal ﬂow in the
pulmonary arteries, ductus arteriosus, and superior vena cava
(SVC), and signiﬁcantly reduced ﬂows in ascending aorta,
DAo, and umbilical vein (UV). The combined ventricular
output (the sum of ascending aortic and main pulmonary
artery ﬂows; CVO) was signiﬁcantly reduced. T2, an MRI
parameter related to blood SaO2, was normal in the UV but
low in all other measured vessels compared to values in
normal fetuses (Figure 3A). Estimating fetal hematocrit
according to gestational age–appropriate reference ranges
and assuming the relationship of the T2 of blood with fetal
SaO2 to be the same as exists for adult blood, the SaO2 and
oxygen content of blood in fetal vessels was calculated
according to our previously published technique.5,6 The
SaO2s across the fetal circulation in this case, compared
with reference ranges, are shown in Figure 3B. By combin-
ing oxygen content measurements in the UV and DAo with
UV ﬂow, fetal oxygen delivery (DO2), consumption (VO2),
and oxygen extraction can be calculated.9,10 The fetus had
normal VO2 (6.9 mL/min/kg, reference: 3.7–10.4) and
reduced DO2 (13.3 mL/min/kg, reference: 12–28.8), which
was associated with a high oxygen extraction fraction (52%,
reference: 21%–49%) (Figure 3C).7Discussion
By using the novel MRI methods, this study provides new
insight into the hemodynamic impact of a persistently slowheart rate and atrioventricular dissociation. Our ﬁndings
reveal that the bradycardia was associated with an increase
in oxygen extraction to maintain fetal VO2 within the normal
range, despite the reduction in fetal DO2 that is caused
by diminished umbilical ﬂow. In keeping with the associa-
tion between CHB and low birth weight reported by
Eronen et al, our fetal biometric measurements were
consistent with IUGR, which may have been due to a
combination of decreased fetal DO2 and transplacental
steroid administration.11,12
Doppler ﬁndings are helpful in the setting of IUGR as
changes in cerebral and placental resistance reﬂect redistrib-
ution of the circulation in response to hypoxia, although the
interpretation of fetal Dopplers is problematic in the setting
of CHB, as the prolonged diastolic time results in reduced
end-diastolic velocities.5,13,14 However, the cerebroplacental
ratio (CPR), which overcomes this problem because it is a
ratio of middle cerebral artery and umbilical artery (UA)
pulsatility index (PI), has been shown to have prognostic
value in the setting of CHB.15 The Doppler ﬁndings
therefore support a hypothesis that the fetal growth restric-
tion had a cardiovascular etiology in this case, in which the
UA PI was high and middle cerebral artery PI was in the
normal range resulting in a CPR below the 5th percentile
throughout the pregnancy. This impression is supported
by the MRI ﬂow measurements, which indicate that at
47%, the percentage of the CVO present in the SVC was
signiﬁcantly higher than in normal fetuses (reference range:
15%–43%).5
Fetal DO2 is determined by umbilical blood ﬂow and the
oxygen content of UV blood.10 DO2 can drop when there is
decreased DO2 from the maternal circulation to the placenta,
interference in diffusion of oxygen across the placenta, or
decreased umbilical blood ﬂow.10 In our case, the low
normal DO2 was caused by reduced UV ﬂow, with normal
UV T2 SaO2 in keeping with normal placental oxygenation
and adequate oxygen exchange. By contrast, fetal VO2 was
unaffected owing to an increase in the arteriovenous differ-
ence in SaO2 between the UV and UA. This adaptation was
also observed in fetal animal models of acute hypoxia,
whereby oxygen extraction increases from 30% to 70%, so
that DO2 can be reduced acutely by almost 50% with no fall
in VO2.16Limitations
The conversion of T2 to SaO2 is derived from adult blood
experiments, and does not account for the slightly longer T2
of fetal hemoglobin. Furthermore, hemoglobin concentration
[Hb] could also inﬂuence the relationship between T2 and
SaO2. Because fetal [Hb] cannot be directly measured, we
estimated [Hb] based on population averages.17 A high [Hb]
would shorten T2, which could exaggerate desaturation.
However, we propose this is unlikely in this case, as the
neonatal [Hb] was close to the normal mean at 17.9 g/dL.
Finally, our T2 mapping technique has not been fully
validated for performing oximetry in blood ﬂowing in fetal
Figure 1 A: M mode at 36 weeks gestation demonstrates a slow ventricular rate and complete dissociation between atrial and ventricular contraction. V ¼
ventricular; A¼ atrial. B: Fetal descending aortic ﬂow curve measured by phase-contrast magnetic resonance with metric optimized gating at 35 weeks gestation.
Fetal cardiac cycle was 1157 ms, corresponding to heart rate 52 beats per minute.
Heart Rhythm Case Reports, Vol 2, No 2, March 2016166
Figure 2 Ultrasound-estimated fetal weight plotted on a reference male singleton weight chart. The fetal weight percentile dropped from 26 weeks to 36
weeks. (23 wk: 35th; 26 wk: 45th; 29 wk: 15th; 33 wk: 10th; 35 wk: 3rd; 36 wk: 2nd).18
Figure 3 A: Magnetic resonance imaging measured ﬂow in major fetal vessels. B: Oxygen saturation calculated based on T2 relaxation time in major fetal
vessels. C: Calculated oxygen consumption (VO2), oxygen delivery (DO2), and oxygen extraction fraction (OEF). Reference ranges for each parameter for
normal fetuses are also shown.5,7 CVO = combined ventricular output; MPA = main pulmonary artery; AAo = ascending aorta; SVC = superior vena cava;
DA = ductus arteriosus; DAo = descending aorta; PBF = pulmonary blood ﬂow; UV = umbilical vein.
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T2 oximetry and conventional blood gases in the vessels of
children with congenital heart disease and in fetal lambs.19,20
Despite the limitations of our technique, its potential value
lies in the fact that there is currently no noninvasive
alternative for making oximetry measurements. The limita-
tions of ultrasound measures of the relative resistance of
different fetal vascular territories have been referred to
above, while ﬂow measurements made using Doppler and
vessel diameters are prone to inaccuracies in measurement of
vessel area, problems with obtaining an adequate angle of
insonation, and problems accounting for the different blood
ﬂow velocities encountered across the lumen of the vessel.21
By contrast, phase-contrast MRI is the noninvasive gold
standard for the quantiﬁcation of ﬂow in fetal vessels, and is
routinely used in postnatal clinical practice for measuring
cardiac output, QP:QS, etc.22 However, the technical
challenges of fetal cardiovascular MRI currently limit this
approach to late gestation, and the hemodynamic measure-
ments obtained in a single “snapshot” may not be reﬂective
of diurnal or gestational age-related changes in fetal
cardiovascular physiology.Conclusion
In conclusion, this is the ﬁrst report of fetal hemodynamic
measurements by MRI in the setting of congenital CHB.
MRI conﬁrmed the “brain-sparing physiology” that was
indicated by the Doppler assessment. Our data provide the
evidence of a cardiac hemodynamic basis for growth
restriction, which may be accentuated by the use of prenatal
steroids in this CHB fetus. Our case also provides evidence
to suggest that despite an increase of approximately 70% in
stroke volume, the bradycardia is associated with a sig-
niﬁcant reduction in fetal CVO, resulting in restricted fetal
growth and elevated oxygen extraction. Of interest, the
dramatic increase in oxygen extraction fraction seen here is
similar to our results in other fetuses with IUGR and those
with forms of congenital heart disease associated with the
lowest CVO, namely severe forms of Ebstein’s anomaly or
tricuspid valve dysplasia, while most forms of congenital
heart disease are associated with normal oxygen extraction
fraction.7 In this case, the heart rate was particularly
low, and it is possible that fetuses in CHB with
higher ventricular rates are able to maintain more normal
CVO. We propose that in future this kind of hemodynamic
assessment could provide a useful adjunct to conventional
ultrasound parameters in the monitoring of fetal well-
being in the setting of CHB. A prospective study with a
larger number of CHB patients will be required to further
clarify the physiological changes and adaptation in
CHB fetuses and also the role of MRI in monitoring CHB
fetuses.Appendix
Supplementary data
Supplementary material cited in this article is available
online at http://dx.doi.org/10.1016/j.hrcr.2015.12.010.References
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